Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

143
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
143

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Apadamtase Alfa: First Approval.

Drugs·2024
Same author

Zuranolone: First Approval.

Drugs·2023
Same author

Correction to: Birch Bark Extract: A Review in Epidermolysis Bullosa.

Drugs·2023
Same author

Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis.

Drugs·2023
Same author

Birch Bark Extract: A Review in Epidermolysis Bullosa.

Drugs·2023
Same author

Omidubicel: First Approval.

Molecular diagnosis & therapy·2023

相关实验视频

Updated: Jul 23, 2025

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

838

弗洛图福拉斯塔特F18:诊断首次获得批准

Young-A Heo1

  • 1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. mdt@adis.com.

Molecular diagnosis & therapy
|July 13, 2023
PubMed
概括

一种新型成像剂Flotufolastat F18获得了美国批准,用于检测前列腺癌转移. 这标志着前列腺癌患者的正电子发射断层扫描 (PET) 诊断的重大进展.

科学领域:

  • 核医学是一种核医学.
  • 放射性药物开发 放射性药物开发
  • 瘤成像学成像学

背景情况:

  • 前列腺癌的诊断依赖于准确的成像来检测转移.
  • 目前的成像剂在灵敏度和特异性方面存在局限性.
  • 前列腺特异性膜抗原 (PSMA) 是前列腺癌的关键生物标志物.

研究的目的:

  • 要总结flotufolastat F 18的发展里程碑.
  • 为了突出美国对flotufolastat F 18的监管批准.
  • 引入flotufolastat F 18作为一种新的PSMA向成像剂.

主要方法:

  • 开发一种标有18F的放射性混合物剂.
  • 针对前列腺特异性膜抗原 (PSMA).
  • 在正子发射断层扫描 (PET) 中的临床应用.

主要成果:

  • 弗洛图福拉斯塔特F 18 (POSLUMA®) 在2023年5月获得美国FDA批准.
  • 已批准用于前列腺癌中PSMA阳性病变的PET成像.
  • 适用于怀疑转移或复发的男性.

更多相关视频

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.4K
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.5K

相关实验视频

Last Updated: Jul 23, 2025

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

838
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.4K
18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
09:57

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

7.5K

结论:

  • 弗洛图福拉斯塔特F 18代表了前列腺癌成像学的重大进步.
  • 该批准有助于改善转移性和复发性前列腺癌的诊断能力.
  • 这种放射性混合剂增强了对PSMA阳性病变的检测.